Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabina Chiaretti

Showing results (131-140 of 172) with videos related to

Pageof 18
Sort By:
Haematologica|May 7, 2016
RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implicationsValentina Gianfelici, Sabina Chiaretti, Sofie Demeyer, et al.
Haematologica|August 1, 2024
Ponatinib alone or with chemo-immunotherapy in heavily pre treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life studyFrancesca Kaiser, Monia Lunghi, Deborah Cardinali, et al.
Haematologica|October 8, 2008
Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing methodIlaria Iacobucci, Annalisa Lonetti, Daniela Cilloni, et al.
Oncotarget|February 18, 2016
Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genesMonica Messina, Sabina Chiaretti, Jiguang Wang, et al.
The Journal of Molecular Diagnostics : JMD|March 7, 2020
Design of a Comprehensive Fluorescence in Situ Hybridization Assay for Genetic Classification of T-Cell Acute Lymphoblastic LeukemiaRoberta La Starza, Valentina Pierini, Tiziana Pierini, et al.
Blood|August 18, 2022
Endothelial cell-leukemia interactions remodel drug responses, uncovering T-ALL vulnerabilitiesLuca Vincenzo Cappelli, Danilo Fiore, Jude M Phillip, et al.
Blood|February 7, 2012
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemiaDavide Rossi, Marco Fangazio, Silvia Rasi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study GroupTorsten Haferlach, Alexander Kohlmann, Lothar Wieczorek, et al.
Molecular Cancer|July 5, 2024
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patientsLenka Hovorkova, Lucie Winkowska, Justina Skorepova, et al.
Blood|July 11, 2009
Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP)Ilaria Iacobucci, Clelia Tiziana Storlazzi, Daniela Cilloni, et al.
Pageof 18

Showing results (131-140 of 172) with videos related to

Sort By:
Pageof 18
Haematologica|May 7, 2016
RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implicationsValentina Gianfelici, Sabina Chiaretti, Sofie Demeyer, et al.
Haematologica|August 1, 2024
Ponatinib alone or with chemo-immunotherapy in heavily pre treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life studyFrancesca Kaiser, Monia Lunghi, Deborah Cardinali, et al.
Haematologica|October 8, 2008
Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing methodIlaria Iacobucci, Annalisa Lonetti, Daniela Cilloni, et al.
Oncotarget|February 18, 2016
Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genesMonica Messina, Sabina Chiaretti, Jiguang Wang, et al.
The Journal of Molecular Diagnostics : JMD|March 7, 2020
Design of a Comprehensive Fluorescence in Situ Hybridization Assay for Genetic Classification of T-Cell Acute Lymphoblastic LeukemiaRoberta La Starza, Valentina Pierini, Tiziana Pierini, et al.
Blood|August 18, 2022
Endothelial cell-leukemia interactions remodel drug responses, uncovering T-ALL vulnerabilitiesLuca Vincenzo Cappelli, Danilo Fiore, Jude M Phillip, et al.
Blood|February 7, 2012
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemiaDavide Rossi, Marco Fangazio, Silvia Rasi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study GroupTorsten Haferlach, Alexander Kohlmann, Lothar Wieczorek, et al.
Molecular Cancer|July 5, 2024
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patientsLenka Hovorkova, Lucie Winkowska, Justina Skorepova, et al.
Blood|July 11, 2009
Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP)Ilaria Iacobucci, Clelia Tiziana Storlazzi, Daniela Cilloni, et al.
Pageof 18